Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor
IntroductionSolid cancers Myeloid cells are prevalent in solid cancers, but they frequently exhibit an anti-inflammatory pro-tumor phenotype that contribute to the immunosuppressive tumor microenvironment (TME), which hinders the effectiveness of cance…